BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27005977)

  • 1. Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resections.
    Tauchi S; Sakai Y; Fujimoto S; Ogawa H; Tane S; Hokka D; Tanaka Y; Nishio W; Yoshimura M; Yanagita E; Itoh T; Hayashi Y; Maniwa Y
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):758-764. PubMed ID: 27005977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psf3 is a prognostic biomarker in lung adenocarcinoma.
    Hokka D; Maniwa Y; Tane S; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Sakai Y; Chen X; Hayashi Y
    Lung Cancer; 2013 Jan; 79(1):77-82. PubMed ID: 23127337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.
    Sun X; Sui W; Huang M; Wang Y; Xuan Y; Wang Z
    Diagn Pathol; 2014 Nov; 9():217. PubMed ID: 25403684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma.
    Kimura K; Tanaka Y; Tauchi S; Kitamura Y; Nishio W; Sakai Y; Hayashi Y; Yoshimura M; Maniwa Y
    Thorac Cancer; 2019 Dec; 10(12):2300-2307. PubMed ID: 31637868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.
    Park JK; Otsuka N; Tomaru U; Suzuki H; Azuma M; Okamoto K; Yamashiro K; Kasahara M
    Hum Pathol; 2018 Oct; 80():104-112. PubMed ID: 29936059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant role of Psf3 expression in non-small-cell lung cancer.
    Tane S; Sakai Y; Hokka D; Okuma H; Ogawa H; Tanaka Y; Uchino K; Nishio W; Yoshimura M; Maniwa Y
    Cancer Sci; 2015 Nov; 106(11):1625-34. PubMed ID: 26291987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
    Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
    J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases.
    Takahashi S; Kamata Y; Tamo W; Koyanagi M; Hatanaka R; Yamada Y; Tsushima T; Takaya S; Fukuda I
    Int J Clin Oncol; 2002 Dec; 7(6):349-55. PubMed ID: 12494250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
    Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
    Shimizu K; Yukawa T; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
    World J Surg Oncol; 2015 Feb; 13():21. PubMed ID: 25888998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
    Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
    Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSF3 marks malignant colon cancer and has a role in cancer cell proliferation.
    Nagahama Y; Ueno M; Haraguchi N; Mori M; Takakura N
    Biochem Biophys Res Commun; 2010 Feb; 392(2):150-4. PubMed ID: 20059967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
    Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.